Skip to content

Key resources

  • Bibliography
    Bibliography
  • Health promotion
    Health promotion
  • Health practice
    Health practice
  • Yarning places
    Yarning places
  • Programs
    Programs
  • Organisations
    Organisations
  • Conferences
    Conferences
  • Courses
    Courses
  • Funding
    Funding
  • Jobs
    Jobs
Australian Indigenous HealthBulletin
 
  • Home
    • » Key resources and services
      • » Health promotion resources
        • » National clinical guidelines and procedures for the use of buprenorphine in the treatment of opioid dependence

National clinical guidelines and procedures for the use of buprenorphine in the treatment of opioid dependence (2006)

Author

Lintzeris N, Clark N, Winstock A, Dunlop A, Muhleisen P, Gowing L, Ali R, Ritter A, Bell J, Quigley A, Mattick RP, Monheit B, White J

City

Canberra

Type

Report

Institution

National Drug Strategy

 

Description

Buprenorphine is registered in Australia for the management of opioid dependence within a framework of medical, social and psychological treatment. Buprenorphine is indicated for use in detoxification and maintenance treatment of opioid dependence. To assist in the safe and effective provision of buprenorphine treatment in Australia, these national guidelines were commissioned by the Commonwealth Department of Health and Ageing under the auspices of the National Expert Advisory Committee on Illicit Drugs (NEACID).

Lintzeris N, Clark N, Winstock A, Dunlop A, Muhleisen P, Gowing L, Ali R, Ritter A, Bell J, Quigley A, Mattick RP, Monheit B, White J. abstract

Links

 
Last updated: 17 April 2014
 
Return to top